NOW ENROLLING

Phase III breast
cancer trial

Patients with locally
advanced or metastatic,
triple-negative or
HR+/HER2– breast cancer

Learn about this
Phase III breast
cancer trial

IPATunity130
BioOncology Genentech

© 2018 Genentech USA, Inc. All rights reserved. BIO/013018/0009